Iconic Therapeutics' Series C - II Round

Iconic Therapeutics raised a round of funding on August 09, 2016.

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The…

Articles about Iconic Therapeutics' Series C - II Round: